MedTrace Logo

Screening for Early Pancreatic Neoplasia (Cancer of the Pancreas Screening or CAPS4 Study)

NCT00714701 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 631

Last updated 2018-09-07

No results posted yet for this study

Summary

CAPS4 is a study at Johns Hopkins Hospital to study the diagnosis and long-term outcomes of screening patients with an increased inherited risk for pancreatic cancer.

Conditions

  • Early Pancreatic Neoplasia
  • Familial Pancreatic Neoplasia

Sponsors & Collaborators

  • The V Foundation for Cancer Research

    collaborator OTHER

  • ChiRhoClin, Inc.

    collaborator INDUSTRY

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    lead OTHER

Principal Investigators

  • Marcia Irene F. Canto, MD, MHS · Johns Hopkins University

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00714701 on ClinicalTrials.gov